Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9P0R6
UPID:
GSKIP_HUMAN
Alternative names:
GSK3beta interaction protein
Alternative UPACC:
Q9P0R6; B3KSZ0; Q9BST1; Q9NWK0
Background:
The GSK3B-interacting protein, also known as GSK3beta interaction protein, plays a pivotal role in cellular processes. It serves as an A-kinase anchoring protein for GSK3B and PKA, regulating their kinase activity towards targets. This protein is instrumental in enhancing Wnt-induced signaling, neuroprotection against oxidative stress, neuron proliferation, and cell cycle progression through various mechanisms including beta-catenin phosphorylation and GSK3B kinase activity inhibition.
Therapeutic significance:
Understanding the role of GSK3B-interacting protein could open doors to potential therapeutic strategies.